share_log

医脉通(02192)发布中期业绩,经调整净溢利1.2亿元 同比增加122% 中期息每股10.67分

Yimaitong (02192) released interim results. Adjusted net profit of 120 million yuan increased 122% year-on-year, and interim interest rate of 10.67 points per share

Zhitong Finance ·  08/29/2023 17:44

According to Zhitong Financial App News, Medical Connect (02192) announced the interim results for the six months ended June 30, 2023. The group achieved revenue of RMB 174 million (same unit), an increase of 31.5% over the previous year; profit attributable to owners of the parent company was 98.718 million yuan, an increase of 266% over the previous year; adjusted net profit of 120 million yuan, an increase of 122% over the previous year; basic profit per share was 13.75 points, and an interim dividend of 10.67 points per share was proposed.

The announcement stated that the increase in revenue was mainly due to increased revenue from precision marketing and enterprise solutions.

Revenue from Precision Marketing and Enterprise Solutions increased by about 33.5% from approximately $118 million for the six months ending June 30, 2022 to approximately $158 million for the same period in 2023, mainly due to user growth and user engagement (as shown by the increase in the number of paid clicks from 3.18 million in the 6 months ending June 30, 2022 to 4.27 million in the 6 months ending June 30, 2022), the Group's medical customer base increased from 84 in the 6 months ending June 30, 2022 to 124 in the same period in 2023; and using the Group The number of medical products marketed by precision marketing and enterprise solutions increased from 181 in the six months ending June 30, 2022 to 253 in the same period in 2023.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment